Saturday, August 09, 2014 8:15:43 PM
1. good growth continues, however, They are still a ways off from turning a profit.
2.they are the only option for about 10% of epilepsy patients that don't respond to medication. Laser ablation for this set of patients is one of their core markets.
3. European Cleartrace set to lauch in Q4
4. The company is happy that Viualase (a company that they work hand in hand with to reduce the need for a surgery room and a MRI room to one room, reducing surgeon time and hospital use)was bought by Medtronic. They see the purchase price to be an indicator of the value of MRIC's potential value. They think Medtronic intends to grow the Visulase product. They are also happy with the expanded sales force that Medtronic brings. They will will get free sales from their efforts.They also think that the Medtronic buy is indicative of the validation of this form and direction of medicine.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM